Startups Enter Race to Create Cancer Screens From DNA, But is it All Too Soon? | Front Line Genomics

Startups Enter Race to Create Cancer Screens From DNA, But is it All Too Soon? | Front Line Genomics

Startups Enter Race to Create Cancer Screens From DNA, But is it All Too Soon?

18 JAN 18

Megan Humphrey

The promise of liquid biopsies is most definitely an exciting one. Boasting the ability to offer noninvasive tests that detect and classify cancer by identifying the tiny bits of DNA that tumours shed into the bloodstream, what’s not to like?